3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Motor Activity
4
Colorectal Neoplasms
3
Lymphoma
2
Colonic Neoplasms
2
Weight Loss
1
Waldenstrom Macroglobulinemia
1
Urinary Bladder Neoplasms
1
Triple Negative Breast Neoplasms
1
Recurrence
1
Rectal Neoplasms
1
Polycystic Ovary Syndrome
1
Obesity
1
Neoplasms
1
Multiple Endocrine Neoplasia Type 1
1
Medical Oncology
1
Malnutrition
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoma, Follicular
1
Lymphoma, B-Cell, Marginal Zone
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Leukemia, B-Cell
1
Glioma
1
Glioblastoma
1
Fasting
1
Esophageal Neoplasms
1
Endometrial Neoplasms
1
Colorectal Cancer Prevention
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Intraductal, Noninfiltrating
1
Breast Neoplasms
1
Interventions
Gemcitabine
56
pembrolizumab
50
Cisplatin
43
Magnetic Resonance Spectroscopy
27
enfortumab vedotin
22
Specimen Handling
22
Nivolumab
22
Cystectomy
18
durvalumab
16
Carboplatin
16
avelumab
15
Mitomycin
14
atezolizumab
13
Docetaxel
13
Cystoscopy
12
Fluorouracil
11
Radiation
9
Transurethral Resection of Bladder
8
Radiotherapy
8
Ipilimumab
8
sacituzumab govitecan
7
Standard of Care
7
Radiosurgery
7
Paclitaxel
7
Immunoglobulin G
7
Disulfides
7
erdafitinib
6
cemiplimab
6
Surveys and Questionnaires
6
Surgical Procedures, Operative
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Urinary Bladder Neoplasms
×
Diet
×
1 year
×
Clear all
NCT06002269
2025-07-20
BOOST
University of Utah
Phase NA
Completed
8 enrolled